Association of Obesity and Pediatric Venous Thromboembolism

Elizabeth E Halvorson1, Sean E Ervin2, Thomas B Russell2

  • 1Departments of Pediatrics, ehalvors@wakehealth.edu.

Hospital Pediatrics
|December 18, 2015
PubMed

Insights

Pediatric venous thromboembolism (VTE) is rising. This study found that increased body mass index (BMI) z score is a significant risk factor for VTE in children and adolescents.

Area of Science:

  • Pediatric Medicine
  • Cardiovascular Health
  • Public Health

Background:

  • The incidence of venous thromboembolism (VTE) is increasing in US pediatric patients.
  • Previous research on obesity's role in pediatric VTE has yielded inconsistent findings.

Purpose of the Study:

  • To investigate the association between body mass index (BMI) and the risk of VTE in pediatric patients.
  • To identify independent predictors of VTE in children and adolescents.

Main Methods:

  • Retrospective chart review of pediatric patients (2-18 years) with VTE.
  • Matched control subjects based on age, gender, and central venous catheter presence.
  • Analysis of risk factors including BMI z score, bacteremia, ICU admission, and oral contraceptive use.

Main Results:

  • A statistically significant association was found between VTE and increased BMI z score (P = .002).
  • Multivariate analysis identified BMI z score (OR: 3.1), bacteremia (OR: 4.9), ICU stay (OR: 2.5), and oral contraceptive use (OR: 17.4) as significant predictors.
  • The majority of VTE events were nonembolic and located in the lower extremities or head and neck.

Conclusions:

  • Overweight and obesity are significantly associated with VTE diagnosis in pediatric patients.
  • Further research is warranted to fully elucidate the relationship between BMI and pediatric VTE.
Abstract

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
681
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
434
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
465
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
379
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
339